With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern
Sharp et al2 showed that, among colorectal cancer survivors, 41% reported cancer-related financial stress, 39% reported financial strain, and 32% reported both stress and strain. These findings highlight how both tangible and intangible financial concerns play a significant role in our patients’ lives. Other studies have highlighted the objective (financial stress) or subjective (financial strain), although most have not examined both; this study highlights how both are important to consider. For instance, patients with cancer are 2.7 times more likely to declare personal bankruptcy (an example of financial stress) in Washington state than those without cancer.3 In addition, those patients with cancer who declared personal bankruptcy were at significantly higher risk of mortality compared with those who did not declare bankruptcy.4 In addition, in a cross-sectional study, financial distress (example of financial strain) was more severe than physical stress, social stress, family stress, and emotional distress.5
Understanding the financial impact of cancer treatment is of utmost importance, because both financial strain and financial stress could harm outcomes in colorectal cancer survivors. Sharp et al2 show that the OR of reporting low HRQoL was significantly higher in patients who reported cancer-related financial stress and financial strain and who experienced both, suggesting that quality of life can be impacted by both of these factors. This is not the first study to examine outcomes in relation to cost of care for colorectal cancer survivors. For example, Shankaran et al6 found that, among patients diagnosed with stage III colon cancer, 38% reported treatment-related financial hardship. Veenstra et al7 found that ≈40% of patients with colorectal cancer receiving adjuvant therapy had to use their savings to make ends meet.
One important limitation to the study, however, is difficulty in generalizability.